Gerard Brophy Avantor, Inc. (AVTR) insider trading activity

Gerard Brophy is EVP, Biopharma Production of Avantor, Inc.. Currently has a direct ownership of 89,032 shares of AVTR, which is worth approximately $2.05 Million. The most recent transaction as insider was on May 17, 2023, when has been sold 19,683 shares (Common Stock) at a price of $20.28 per share, resulting in proceeds of $399,171. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 89K

0% 3M change

0% 12M change

Total Value Held $2.05 Million

Gerard Brophy Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 17 2023	SELL Payment of exercise price or tax liability	$399,171 $20.28 p/Share	19,683 Reduced 18.11%	89,032 Common Stock
Mar 03 2023	SELL Open market or private sale	$97,850 $25.0 p/Share	3,914 Reduced 3.48%	108,715 Common Stock
Feb 27 2023	SELL Open market or private sale	$76,475 $25.0 p/Share	3,059 Reduced 2.64%	112,629 Common Stock
Feb 25 2023	SELL Payment of exercise price or tax liability	$50,224 $24.62 p/Share	2,040 Reduced 1.73%	115,688 Common Stock
Feb 24 2023	BUY Grant, award, or other acquisition	-	20,308 Added 14.71%	117,728 Common Stock
Feb 23 2023	SELL Payment of exercise price or tax liability	$46,548 $24.59 p/Share	1,893 Reduced 1.91%	97,420 Common Stock
Feb 20 2023	SELL Payment of exercise price or tax liability	$75,386 $24.54 p/Share	3,072 Reduced 3.0%	99,313 Common Stock
Feb 02 2023	SELL Open market or private sale	$284,155 $25.06 p/Share	11,339 Reduced 9.97%	102,385 Common Stock
Jan 31 2023	SELL Payment of exercise price or tax liability	$363,781 $23.9 p/Share	15,221 Reduced 11.8%	113,724 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	38,737 Added 23.1%	128,945 Common Stock
Jan 02 2023	SELL Payment of exercise price or tax liability	$141,872 $21.09 p/Share	6,727 Reduced 6.94%	90,208 Common Stock
May 20 2022	SELL Open market or private sale	$612,986 $31.27 p/Share	19,603 Reduced 16.82%	96,935 Common Stock
May 17 2022	SELL Payment of exercise price or tax liability	$616,668 $31.33 p/Share	19,683 Reduced 14.45%	116,538 Common Stock
Mar 01 2022	SELL Open market or private sale	$69,871 $34.47 p/Share	2,027 Reduced 1.47%	136,221 Common Stock
Feb 25 2022	SELL Payment of exercise price or tax liability	$72,302 $35.39 p/Share	2,043 Reduced 1.46%	138,248 Common Stock
Feb 23 2022	SELL Open market or private sale	$103,364 $33.79 p/Share	3,059 Reduced 2.39%	125,181 Common Stock
Feb 23 2022	BUY Grant, award, or other acquisition	-	15,110 Added 9.72%	140,291 Common Stock
Feb 20 2022	SELL Payment of exercise price or tax liability	$104,448 $34.0 p/Share	3,072 Reduced 2.34%	128,240 Common Stock
Jan 05 2022	SELL Open market or private sale	$446,446 $38.65 p/Share	11,551 Reduced 8.09%	131,312 Common Stock
Jan 03 2022	SELL Open market or private sale	$2,422,472 $40.77 p/Share	59,418 Reduced 29.37%	142,863 Common Stock
Jan 03 2022	BUY Exercise of conversion of derivative security	$1,096,262 $18.45 p/Share	59,418 Added 22.7%	202,281 Common Stock
Jan 02 2022	SELL Payment of exercise price or tax liability	$274,584 $42.14 p/Share	6,516 Reduced 4.36%	142,863 Common Stock
Jul 30 2021	SELL Open market or private sale	$3,021,095 $37.24 p/Share	81,125 Reduced 35.19%	149,379 Common Stock
Jul 30 2021	BUY Exercise of conversion of derivative security	$1,882,100 $23.2 p/Share	81,125 Added 26.03%	230,504 Common Stock
May 20 2021	SELL Open market or private sale	$609,653 $31.1 p/Share	19,603 Reduced 11.6%	149,379 Common Stock

Gerard Brophy

EVP, Biopharma Production

Radnor, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTR shares.

Notify only if

Value

Insider Trading

Get notified when an Avantor, Inc. insider buys or sells AVTR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Avantor, Inc.

Track Activities on AVTR

Account